USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Future Impact of Emerging Technologies
24-Feb-2015
Asia Pacific
Market Research
P874-01-00-00-00
LS00150-AP-MR_16991
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.
Key Findings
Key Findings (continued)
Key Findings—Options in the Oncology Drug Delivery Market
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Technologies to Watch
3 Key Predictions
Market Background
Market Segmentation
Total Oncology Drug Delivery Market—Segmentation by Type of Delivery
Total Oncology Drug Delivery Market—Segmentation by Type of Delivery (continued)
Total Oncology Drug Delivery Market—Segmentation by Region
Total Oncology Drug Delivery Market—Segmentation by Top 5 Competitors
Cancer Pain Management Market
New Market Opportunities
Pipeline of Products in Oncology Drug Delivery Market
Attractiveness in Oncology Drug Delivery Market
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast Discussion
Oral or Injectable Drug Delivery Systems—New Options for Payors
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Porter’s 5 Force Analysis
Market Engineering Measurements
Injectable Drug Delivery System Segment—Revenue Forecast
Revenue Forecast Discussion
Injectable Drug Delivery System Segment—Competitive Assessment
Market Engineering Measurements
Oral Drug Delivery System Segment
Revenue Forecast Discussion
Oral Oncolytic—Past, Present, and Future Options
Oral Drug Delivery System Segment—Competitive Assessment
US Market—Overview of Oncology Drug Delivery Market
US Oncology Drug Delivery Market—Revenue Forecast
Europe Market—Overview of Cancer Drug Delivery System
Europe Oncology Drug Delivery Market—Revenue Forecast
RoW Oncology Drug Delivery Market—Overview of Cancer Drug Delivery System
RoW Oncology Drug Delivery Market—Revenue Forecast
Nano Drug Delivery—Future of Cancer Drug Delivery Systems
Currently Marketed Nano Drug Delivery Systems—All Injectable Drug Delivery Systems
Nano Drug Delivery System—Segmentation
Attractive Nano Drug Delivery Systems
Key Nano Drug Delivery Systems—High Potential and Equally Attractive Technology for Future
Intra-nasal Drug Delivery—Next Option in Cancer Pain
Becton, Dickinson and Company (BD)
Evotec AG
Juno Therapeutics, Inc.
West Pharmaceuticals
NEONC Technologies Inc. (NTI)
Future of Cancer Drugs—Drugs in Cases where Tumour will no Longer Respond to Standard Therapy
Conclusions
Frost & Sullivan Awards
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Siddharth Dutta |
| WIP Number | P874-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Oncology Drug Delivery Market
$4,950.00
Special Price $3,712.50 save 25 %